BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37035538)

  • 1. Biofilm Formation and Phospholipase and Proteinase Production in
    Bisso BN; Makuété AL; Tsopmene JU; Dzoyem JP
    ScientificWorldJournal; 2023; 2023():6080489. PubMed ID: 37035538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploitation of the antifungal and antibiofilm activities of plumbagin against
    Qian W; Wang W; Zhang J; Fu Y; Liu Q; Li X; Wang T; Zhang Q
    Biofouling; 2022 Jul; 38(6):558-574. PubMed ID: 35818738
    [No Abstract]   [Full Text] [Related]  

  • 3. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
    Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising
    Qian W; Li X; Liu Q; Lu J; Wang T; Zhang Q
    Front Cell Infect Microbiol; 2022; 12():884793. PubMed ID: 35669114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity study of the monoterpene thymol against
    Teixeira APC; Nóbrega RO; Lima EO; Araújo WO; Lima IO
    Nat Prod Res; 2020 Sep; 34(18):2630-2633. PubMed ID: 30584769
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans.
    Wang WJ; Liu CC; Li YT; Li MQ; Fu YT; Li XC; Jie-Kang ; Qian WD
    Curr Microbiol; 2022 Aug; 79(10):293. PubMed ID: 35972650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
    Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro Antifungal Activity of a Novel Antimicrobial Peptide AMP-17 Against Planktonic Cells and Biofilms of
    Yang L; Tian Z; Zhou L; Zhu L; Sun C; Huang M; Peng J; Guo G
    Infect Drug Resist; 2022; 15():233-248. PubMed ID: 35115792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
    da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
    Cordeiro RA; Evangelista AJJ; Serpa R; Marques FJF; Melo CVS; Oliveira JS; Franco JDS; Alencar LP; Bandeira TJPG; Brilhante RSN; Sidrim JJC; Rocha MFG
    Microbiology (Reading); 2016 Feb; 162(2):309-317. PubMed ID: 26645478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo synergistic effects of hydroxychloroquine and itraconazole on Cryptococcus neoformans.
    Wang X; Long X; Jia S; Zhu J; Zhou Z; Ahmed S; Jiang Y; Jiang Y
    Folia Microbiol (Praha); 2023 Aug; 68(4):595-605. PubMed ID: 36753031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthraquinones against
    Araújo GDS; Brilhante RSN; Rocha MGD; Aguiar L; Castelo-Branco DSCM; Guedes GMM; Sidrim JJC; Pereira Neto WA; Rocha MFG
    J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38530134
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
    Pini G; Faggi E; Campisi E
    Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pomegranate sarcotesta lectin (PgTeL) inhibits planktonic growth and disrupts biofilm formed by Cryptococcus neoformans.
    Ferreira GRS; da Silva PM; Lopes W; Feitosa APS; Coelho LCBB; Brayner FA; Alves LC; Paiva PMG; de Moura MC; Vainstein MH; Napoleão TH
    J Appl Microbiol; 2023 Jul; 134(7):. PubMed ID: 37437916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade.
    Naicker SD; Mpembe RS; Maphanga TG; Zulu TG; Desanto D; Wadula J; Mvelase N; Maluleka C; Reddy K; Dawood H; Maloba M; Govender NP;
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008137. PubMed ID: 32231354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
    Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
    Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.